RxDoctor Payments Data

Peter Leonovicz, MD

Urology · Milwaukee, WINPI 1972594976

Payments from drug & device makers

What this record shows

This record is dominated by education: $5,537 of the $9,103 with a category attached, or 60.8%. Intuitive Surgical accounts for 91.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $3,894 and has fallen 81.6% since, to $718 in 2025. Among urology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,103in general payments, 2019–2025

Across 31 payments — averaging $293.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$8K
  • Calyxo, Inc.$614
  • Urogen Pharma, Inc.$109
  • AbbVie$20
  • Pfizer$15
  • Travere Therapeutics, Inc.$2

What the payments were for

  • Travel & lodging$2,06623%
  • Food & beverage$1,49016%
  • Education$5,53761%
  • Gifts$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,103 in reported general payments places this provider in the 90th percentile of 215 urology providers in Wisconsin.

See all urology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$193,546
Medicare patients
462
Services billed
1,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron197$137,411
GemtesaVibegron32$22,847
Tamsulosin Hcl597$7,018
Trospium Chloride ErTrospium Chloride14$2,793
Alfuzosin Hcl ErAlfuzosin Hcl119$2,508
Finasteride150$1,858
Methenamine Hippurate13$1,169
Dutasteride28$822
Trimethoprim12$696
Acetic Acid27$637
Tolterodine Tartrate ErTolterodine Tartrate11$549
Cephalexin80$464
Solifenacin Succinate14$421
Trospium Chloride12$326
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim49$326

Paid to pharmacies, not to this prescriber.

Other urology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →